Study protocol for a pilot, open-label, prospective, and observational study to evaluate the pharmacokinetics of drugs administered to patients during extracorporeal circulation; potential of in vivo cytochrome p450 phenotyping to optimise pharmacotherapy

Loading...
Thumbnail Image
File version

Version of Record (VoR)

Author(s)
Adiraju, SKS
Shekar, K
Tesar, P
Naidoo, R
Rapchuk, I
Belz, S
Fraser, JF
Smith, MT
Ghassabian, S
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2019
Size
File type(s)
Location
Abstract

Pharmacokinetic alterations of medications administered during surgeries involving cardiopulmonary bypass (CPB) and extracorporeal membrane oxygenation (ECMO) have been reported. The impact of CPB on the cytochrome P450 (CYP) enzymes’ activity is the key factor. The metabolic rates of caffeine, dextromethorphan, midazolam, omeprazole, and Losartan to the CYP-specific metabolites are validated measures of in vivo CYP 1A2, 2D6, 3A4, 2C19, and 2C9 activities, respectively. The study aim is to assess the activities of major CYPs in patients on extracorporeal circulation (EC). This is a pilot, prospective, open-label, observational study in patients undergoing surgery using EC and patients undergoing laparoscopic cholecystectomy as a control group. CYP activities will be measured on the day, and 1–2 days pre-surgery/3–4 days post-surgery (cardiac surgery and Laparoscopic cholecystectomy) and 1–2 days after starting ECMO, 1–2 weeks after starting ECMO, and 1–2 days after discontinuation from ECMO. Aforementioned CYP substrates will be administered to the patient and blood samples will be collected at 0, 1, 2, 4, and 6 h post-dose. Major CYP enzymes’ activities will be compared in each participant on the day, and before/after surgery. The CYP activities will be compared in three study groups to investigate the impact of CYPs on EC.

Journal Title

Methods and Protocols

Conference Title
Book Title
Edition
Volume

2

Issue

2

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Item Access Status
Note
Access the data
Related item(s)
Subject

Cardiology (incl. cardiovascular diseases)

Pharmacology and pharmaceutical sciences

Persistent link to this record
Citation

Adiraju, SKS; Shekar, K; Tesar, P; Naidoo, R; Rapchuk, I; Belz, S; Fraser, JF; Smith, MT; Ghassabian, S, Study protocol for a pilot, open-label, prospective, and observational study to evaluate the pharmacokinetics of drugs administered to patients during extracorporeal circulation; potential of in vivo cytochrome p450 phenotyping to optimise pharmacotherapy, Methods and Protocols, 2019, 2 (2), pp. 38

Collections